Clearmind Medicine Inc. CMND
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -95.71%
- 1 year
- -99.79%
- Open
- 5.83
- Prev close
- 5.85
- Mkt cap
- 3.16M
- Vol
- 10.47K
- Avg vol
- 58.53K
- EPS
- -461.20
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 5.83
- High
- 6.50
- Forward P/E
- 0.00
- Beta
- -1.51
- Short ratio
- 1.88
- Inst. own
- 16.02%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.39
- 200-d avg
- 1.33
- 1y target
- 0.00
5D chart
Signals (31)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 30, 12:10 PM | 1 day ago |
| SMA: Bullish | Oct 30, 10:30 AM | 1 day ago |
| MACD: Buy Signal | Oct 30, 10:30 AM | 1 day ago |
| MACD: Sell Signal | Oct 30, 9:35 AM | 1 day ago |
| MACD: Buy Signal | Oct 29, 12:00 PM | 2 days ago |
| RSI: Oversold | Oct 29, 10:50 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 9:45 AM | 2 days ago |
| SMA: Bearish | Oct 29, 9:40 AM | 2 days ago |
| SMA: Bearish | Oct 29, 9:40 AM | 2 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 2 days ago |
| MACD: Buy Signal | Oct 28, 3:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 2:35 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 1:25 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:05 PM | 3 days ago |
| SMA: Bearish | Oct 28, 12:35 PM | 3 days ago |
| RSI: Oversold | Oct 28, 12:35 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 11:55 AM | 3 days ago |
| SMA: Bullish | Oct 28, 10:40 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 10:40 AM | 3 days ago |
| RSI: Overbought | Oct 28, 10:40 AM | 3 days ago |
| MACD: Sell Signal | Oct 27, 3:40 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:20 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 3:10 PM | 4 days ago |
| RSI: Overbought | Oct 27, 3:10 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 10:20 AM | 4 days ago |
| SMA: Bearish | Oct 27, 10:00 AM | 4 days ago |
| RSI: Overbought | Oct 26, 3:50 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 1:55 PM | 5 days ago |
| RSI: Oversold | Oct 26, 12:55 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:15 PM | 5 days ago |
| RSI: Oversold | Oct 26, 12:15 PM | 5 days ago |
News
1 day ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers NRX Pharmaceuticals (NASDAQ:NRXP) shares increased by 12.0% to $2.98 during Friday's pre-market session. The market value of their outstanding shares is at $115.1 million. Intensity…
-
4 days ago benzinga.com
Clearmind Medicine Completes Participant Recruitment For First Segment Of Part B Of Its Phase I/IIa Clinical Study Of CMND-100 To Treat Alcohol Use Disorder
Clearmind Medicine Inc. (Nasdaq: CMND) ("Clearmind" or the "Company"), a clinical-stage biopharmaceutical company advancing non-hallucinogenic psychedelic-derived neuroplastogens for scalable…
4 days ago globenewswire.com
Clearmind Successfully Completes Patient Recruitment for the First Alcohol Use Disorder Cohort of its CMND-100 Phase I/IIa Clinical Trial
Milestone advances Clearmind's clinical program as the company continues to develop CMND‑100 as a potential novel therapeutic candidate for alcohol use disorder
-
2 weeks ago benzinga.com
Clearmind Medicine's Charging Robotics Subsidiary Rolls Out Autonomous Vehicle Charging Platform
Clearmind Medicine Inc. (NASDAQ:CMND) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation
-
3 weeks ago benzinga.com
Clearmind Medicine Publishes Patient Application In Japan For Its Compositions And Methods For Treating Dyskinesia
Clearmind Medicine Inc. (Nasdaq: CMND) (the "Company"), a clinical-stage biopharmaceutical company advancing non-hallucinogenic psychedelic-derived neuroplastogen for scalable treatment of…